Recall Z-2044-2023— Appliedvr
Class II · Completed
Class II FDA medical device recall by Appliedvr, initiated 2023-02-27. FDA's recall record names no specific 510(k) clearance for this event. Product: RelieVR REF: RVX-2002, Rx Only. Virtual reality behavioral therapy device for pain relief.. Reason: There is the potential for the program software to malfunction which will not allow it to move forward to the next session..
- Recalling firm
- Appliedvr
- Classification
- Class II
- Status
- Completed
- Initiated
- 2023-02-27
- Firm location
- Van Nuys, CA, United States
Product description
RelieVR REF: RVX-2002, Rx Only. Virtual reality behavioral therapy device for pain relief.
Reason for recall
There is the potential for the program software to malfunction which will not allow it to move forward to the next session.
Data sourced from openFDA. This site is unofficial and independent of the FDA.